ストックスクリーナーアプリを入手
1.50
3.45%
0.05
アフターアワーズ：
1.53
0.03
+2.00%
前日終値:
$1.45
開ける：
$1.47
24時間の取引高:
584.40K
Relative Volume:
3.54
時価総額：
$24.11M
収益：
-
当期純損益:
$-8.29M
株価収益率:
-2.1429
EPS:
-0.7
ネットキャッシュフロー:
$-6.47M
1週間 パフォーマンス:
+9.49%
1か月 パフォーマンス:
+4.17%
6か月 パフォーマンス:
+12.78%
1年 パフォーマンス:
+0.67%
1日の値動き範囲:
$1.45
$1.63
1週間の範囲:
$1.30
$1.63
52週間の値動き範囲:
$0.94
$1.9195
NanoViricides Inc Stock (NNVC) Company Profile
NNVC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NNVC
NanoViricides Inc
|
1.50 | 25.27M | 0 | -8.29M | -6.47M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2015-02-11 | 開始されました | Midtown Partners | Strong Buy |
NanoViricides Inc (NNVC) 最新ニュース
How institutional ownership impacts NanoViricides Inc. stock2025 Earnings Surprises & Reliable Entry Point Trade Alerts - newser.com
NanoViricides Dual Track Clinical Strategy Explained by a Research ReportBroad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage for MPox and also for Acute Respiratory Infections of All Viruses - Norwich Bulletin
NanoViricides Advances Dual-Track Clinical Strategy for Broad-Spectrum Antiviral Drug Candidate NV-387 - citybuzz -
Identifying reversal signals in NanoViricides Inc.July 2025 Retail & Consistent Profit Trade Alerts - newser.com
Understanding NanoViricides Inc.’s price movementWeekly Investment Report & Long-Term Safe Return Strategies - newser.com
Detecting price anomalies in NanoViricides Inc. with AI2025 Volatility Report & Weekly Hot Stock Watchlists - newser.com
Phase II start by late CY25/early CY26: NanoViricides' NV-387 pursues MPox and broad respiratory virus trials - Stock Titan
Is NanoViricides Inc. stock ideal for retirement investorsJuly 2025 Review & Daily Chart Pattern Signals - newser.com
Nanoviricides: Dual track clinical development during 2026Preview | NYSE-A:NNVC - Proactive financial news
How NanoViricides Inc. (NV3P) stock trades after rate cutsMarket Volume Summary & Low Risk Profit Maximizing Plans - newser.com
News impact scoring models applied to NanoViricides Inc.July 2025 Final Week & Free Expert Approved Momentum Trade Ideas - newser.com
Can NanoViricides Inc. (NV3P) stock attract ESG investments2025 Price Targets & Capital Protection Trade Alerts - newser.com
Using data filters to optimize entry into NanoViricides Inc.Portfolio Update Report & Breakout Confirmation Trade Signals - newser.com
NanoViricides, Inc. Has Filed its Annual Report - The Daily Jeffersonian
Is NanoViricides Inc. stock in buy zone after pullbackMarket Activity Recap & Long-Term Growth Portfolio Plans - newser.com
Exit strategy if you’re trapped in NanoViricides Inc.Quarterly Earnings Summary & Short-Term High Return Strategies - newser.com
Why global investors buy NanoViricides Inc. stockTake Profit & Weekly Breakout Watchlists - newser.com
Is NanoViricides Inc. (NV3P) stock a safe buy pre earnings2025 Winners & Losers & Free Safe Capital Growth Stock Tips - newser.com
Using Bollinger Bands to evaluate NanoViricides Inc.July 2025 Review & Reliable Price Breakout Alerts - newser.com
How to read the order book for NanoViricides Inc.2025 Volatility Report & Daily Oversold Bounce Ideas - newser.com
Is NanoViricides Inc. (NV3P) stock undervalued by metricsExit Point & Risk Controlled Swing Alerts - newser.com
Trend analysis for NanoViricides Inc. this weekPortfolio Value Report & Safe Entry Momentum Tips - newser.com
NanoViricides Inc (AMEX: NNVC) stock has achieved $1.4600 in the past week - fostersleader.com
What makes NanoViricides Inc. stock appealing to growth investorsJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - newser.com
NanoViricides Inc (NNVC) 財務データ
収益
当期純利益
現金流量
EPS
1.84%
0.50%
大文字化:
|
ボリューム (24 時間):